These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17363064

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.
    Poggi SH, Goodwin K, Hill JM, Brenneman DE, Tendi E, Schinelli S, Abebe D, Spong CY.
    Am J Obstet Gynecol; 2003 Sep; 189(3):790-3. PubMed ID: 14526315
    [Abstract] [Full Text] [Related]

  • 26. A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein.
    Gozes I, Bassan M, Zamostiano R, Pinhasov A, Davidson A, Giladi E, Perl O, Glazner GW, Brenneman DE.
    Ann N Y Acad Sci; 1999 Sep; 897():125-35. PubMed ID: 10676441
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.
    Braitch M, Kawabe K, Nyirenda M, Gilles LJ, Robins RA, Gran B, Murphy S, Showe L, Constantinescu CS.
    Neuroimmunomodulation; 2010 Sep; 17(2):120-5. PubMed ID: 19923857
    [Abstract] [Full Text] [Related]

  • 31. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y, Sayas CL, Malishkevich A, Gozes I.
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [Abstract] [Full Text] [Related]

  • 32. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
    Gozes I.
    Curr Pharm Des; 2011 Sep; 17(31):3413-7. PubMed ID: 21902667
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
    Gozes I, Divinski I.
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S37-41. PubMed ID: 15665412
    [Abstract] [Full Text] [Related]

  • 38. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).
    Magen I, Gozes I.
    Neuropeptides; 2013 Dec; 47(6):489-95. PubMed ID: 24210139
    [Abstract] [Full Text] [Related]

  • 39. NAP protects hippocampal neurons against multiple toxins.
    Zemlyak I, Manley N, Sapolsky R, Gozes I.
    Peptides; 2007 Oct; 28(10):2004-8. PubMed ID: 17869381
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.